Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Clinical Characteristics and Outcomes of COVID-19 in HSCT Recipients

Clarisse MARTINS Machado, MD PhD, Mariana Nassif Kerbauy, MD, Iago Colturato, MD, Leonardo Javier Arcuri, Ana Cláudia Ferrari dos Santos, MSc, Fernanda Rodrigues Silva, MD, Anderson João Simioni, Juliana Folloni Fernandes, MD, Mair Pedro de Souza, MD, Vergilio Rensi Colturato, MD, Nelson Hamerschlak, MD PhD

Blood (2020) 136 (Supplement 1): 19.

https://doi.org/10.1182/blood-2020-141959

Published: 2020

Journal Articles

Final Results of a Dual-Institution Phase I Clinical Trial of Targeted Marrow Irradiation (TMI) Intensification of Reduced-Intensity Fludarabine/Busulfan (Flu/Bu) Conditioning for Allogeneic Hematopoietic Cell Transplantation for Medically Frail Patients with High-Risk Hematological Malignancies

Naveed Ali, MD, Ana Carolina Pires de Rezende, MD, Folashade Otegbeye, MBBChir,MPH, Mariana Nassif Kerbauy, MD, Brenda W. Cooper, MD, David Mansur, MD, Gisele Pereira, PhD, Roberto Sakuraba, MD, Benjamin K. Tomlinson, MD, Kirsten M Boughan, DO, Cinthya Correa Silva, MD, Leland Metheny, III, MD, Andreza Feitosa Ribeiro, MD, Molly M Gallogly, MDPhD, Ehsan Malek, MD, EDuardo Weltman, MD, Marcos de Lima, MD, Nelson Hamerschlak, MD PhD, Paolo F Caimi, MD

Blood (2020) 136 (Supplement 1): 29–30.

https://doi.org/10.1182/blood-2020-142197

Published: 2020

Journal Articles

Implementation of a Public Lymphoma Clinic in a Private Hospital in Brazil: Challenges and Impact of Delayed Diagnosis in Patients with Diffuse Large B Cell Lymphoma

Guilherme Fleury Perini, Larissa LC Teixeira, Carolina Feres, MD, Mariana Nassif Kerbauy, MD, Leonardo Javier Arcuri, Denise Cunha Pasqualin, Alanna MPS Bezerra, Diogo DG Bugano, Nelson Hamerschlak, MD PhD

Blood (2020) 136 (Supplement 1): 13–14.

https://doi.org/10.1182/blood-2020-142738

Published: 2020

Journal Articles

Cell of Origin Impacts Δsuvmax Cutoff for Prediction of Relapse in Patients with Diffuse Large B-Cell Lymphoma

Carolina Feres, MD, Leonardo Javier Arcuri, Larissa LC Teixeira, Mariana Nassif Kerbauy, MD, Denise Cunha Pasqualin, Alanna MPS Bezerra, Guilherme de Carvalho Campos Neto, MD, Rafael Fernandes Nunes, Aline Fernanda Ramos, MD, Michelle De Paula Jacinto, Guilherme Fleury Perini, MD, Nelson Hamerschlak, MD PhD

Blood (2020) 136 (Supplement 1): 23–24.

https://doi.org/10.1182/blood-2020-143305

Published: 2020

Journal Articles

Early MMF Discontinuation Is an Effective and Safe Measure to Decrease CMV Reactivation in Patients Submitted to Unmanipulated Haploidentical Transplant with Post-Cy Immunosuppression

Mariana Nassif Kerbauy, MD, Lucila Nassif Kerbauy, MD, Iracema Esteves, MD PhD, Jairo Jose Nascimento Sobrinho, MD, Jose Mauro Kutner, MD PhD, Morgani Rodrigues, MD, Fabio Pires de Souza Santos, MD, Guilherme Fleury Perini, MD, Luis Fernando Aranha Camargo, MD PhD, Jacyr Pasternak, MD PhD, Juliana Folloni Fernandes, MD, Luiz Fernando Alves Lima Mantovani, MD, Angela Mandelli Venancio, MD, Gabriele Zamperlini Netto, MD, Cinthya Corrêa da Silva, Fabio Rodrigues Kerbauy, MD PhD, Andreza Alice Feitosa Ribeiro, MDPhD, Nelson Hamerschlak, MD PhD

Blood (2016) 128 (22): 2216.

https://doi.org/10.1182/blood.V128.22.2216.2216

Published: 2016

Journal Articles

Autologous Stem Cell Transplantation (ASCT) As Upfront Treatment in Primary Central Nervous System Lymphoma (PCNSL): A Systematic Review and Comparative Analysis in Clinical Trials Setting

Mariana Nassif Kerbauy, MD, Fabio Ynoe de Moraes, MD, Lucila Nassif Kerbauy, MD, Iracema Esteves, MD PhD, Guilherme Fleury Perini, MD, Fabio Pires de Souza Santos, MD, Andreza Alice Feitosa Ribeiro, MD PhD, Fabio Rodrigues Kerbauy, MD PhD, Nelson Hamerschlak, MD PhD

Blood (2016) 128 (22): 2272.

https://doi.org/10.1182/blood.V128.22.2272.2272

Published: 2016

Journal Articles

Fertility Outcomes after Allogeneic Hematopoietic Stem Cell Transplants Conditioned with Busulfan 4 Mg/Kg and Cyclophosphamide 200 Mg/Kg to Treat Severe Aplastic Anemia

Mariana Nassif Kerbauy, MD, Livia Caroline Barbosa Mariano, MD, Erick Menezes, MD, Evandro Dantas, MD, Jayr Schmidt Sobrinho, MD, Marina M Nascimento, MD, Roberto Silva, MD, Maria Cristina Macedo, MD, Sandra Gualandro, MD PhD, Adriana Seber, MD MS

Blood (2015) 126 (23): 4460.

https://doi.org/10.1182/blood.V126.23.4460.4460

Published: 2015

NARROW

Clinical Characteristics and Outcomes of COVID-19 in HSCT Recipients

Final Results of a Dual-Institution Phase I Clinical Trial of Targeted Marrow Irradiation (TMI) Intensification of Reduced-Intensity Fludarabine/Busulfan (Flu/Bu) Conditioning for Allogeneic Hematopoietic Cell Transplantation for Medically Frail Patients with High-Risk Hematological Malignancies

Implementation of a Public Lymphoma Clinic in a Private Hospital in Brazil: Challenges and Impact of Delayed Diagnosis in Patients with Diffuse Large B Cell Lymphoma

Cell of Origin Impacts Δsuvmax Cutoff for Prediction of Relapse in Patients with Diffuse Large B-Cell Lymphoma

Early MMF Discontinuation Is an Effective and Safe Measure to Decrease CMV Reactivation in Patients Submitted to Unmanipulated Haploidentical Transplant with Post-Cy Immunosuppression

Autologous Stem Cell Transplantation (ASCT) As Upfront Treatment in Primary Central Nervous System Lymphoma (PCNSL): A Systematic Review and Comparative Analysis in Clinical Trials Setting

Fertility Outcomes after Allogeneic Hematopoietic Stem Cell Transplants Conditioned with Busulfan 4 Mg/Kg and Cyclophosphamide 200 Mg/Kg to Treat Severe Aplastic Anemia

Email alerts

ASH Publications

American Society of Hematology

Clinical Characteristics and Outcomes of COVID-19 in HSCT Recipients

Final Results of a Dual-Institution Phase I Clinical Trial of Targeted Marrow Irradiation (TMI) Intensification of Reduced-Intensity Fludarabine/Busulfan (Flu/Bu) Conditioning for Allogeneic Hematopoietic Cell Transplantation for Medically Frail Patients with High-Risk Hematological Malignancies

Implementation of a Public Lymphoma Clinic in a Private Hospital in Brazil: Challenges and Impact of Delayed Diagnosis in Patients with Diffuse Large B Cell Lymphoma

Cell of Origin Impacts Δsuvmax Cutoff for Prediction of Relapse in Patients with Diffuse Large B-Cell Lymphoma

Early MMF Discontinuation Is an Effective and Safe Measure to Decrease CMV Reactivation in Patients Submitted to Unmanipulated Haploidentical Transplant with Post-Cy Immunosuppression

Autologous Stem Cell Transplantation (ASCT) As Upfront Treatment in Primary Central Nervous System Lymphoma (PCNSL): A Systematic Review and Comparative Analysis in Clinical Trials Setting

Fertility Outcomes after Allogeneic Hematopoietic Stem Cell Transplants Conditioned with Busulfan 4 Mg/Kg and Cyclophosphamide 200 Mg/Kg to Treat Severe Aplastic Anemia

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only